Simon Hjerrild
banner
simonhjerrild.bsky.social
Simon Hjerrild
@simonhjerrild.bsky.social
Associate professor, MD, PhD. Psychiatrist at day, sleeping at night✌️
Research in mood disorders and ADHD.
📍Aarhus University Hospital + 📍Mental Health Center Copenhagen 🇩🇰
Neurofeedback most likely not effective in the treatment of ADHD:

“Conclusions and relevance: Overall, neurofeedback did not appear to meaningfully benefit individuals with ADHD, clinically or neuropsychologically, at the group level.”

pubmed.ncbi.nlm.nih.gov/39661381/
Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis - PubMed
Overall, neurofeedback did not appear to meaningfully benefit individuals with ADHD, clinically or neuropsychologically, at the group level. Future studies seeking to identify individuals with ADHD wh...
pubmed.ncbi.nlm.nih.gov
December 12, 2024 at 12:28 PM
Sometimes life is a cognitive aggression…
December 9, 2024 at 4:00 PM
The Danish Medical Journal send all who served as peer reviewers a christmas present to thank them for their service during the year.

A lot of journals should learn from this.

👌 @ugeskriftet.bsky.social
December 6, 2024 at 7:46 PM
Being a psychiatrist engaging in public discussions on mental health and psychiatry can be a very constructive and positive experience.

But most of the time it's just ad hominems, vitriol, strawmen, threats. It's deeply frustrating an is preventing us from advancing.
November 28, 2024 at 7:43 AM
What personality traits are associated with virtuous victimhood signalling?

While I have great sympathy for victims of abuse and neglect, sometimes a very active declaration of victimhood can be indicative of something else going on.

gwern.net/doc/psycholo...
gwern.net
November 27, 2024 at 8:08 AM
Only 9.1% of adults received minimally adequate treatment for depression worldwide. This is extremely concerning given the impact of depression on distress, daily functioning, and life quality.

www.thelancet.com/journals/lan...
Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021
Despite many gaps in the available data, estimates show that, globally, most individuals with major depressive disorder do not receive MAT. Services must improve to reach a global coverage that better...
www.thelancet.com
November 20, 2024 at 3:32 PM